Medicare Enrolled
Dr. Suneya Hogarty, M.D.
Optician · Goldsboro, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hogarty from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hogarty?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hogarty
Dr. Suneya Hogarty is an optician specialist in Goldsboro, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hogarty performed 148,812 Medicare services across 1,287 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hogarty received a total of $45,578 from 51 pharmaceutical and/or device companies across 777 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hogarty is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in NC
$45,578 industry payments
Medicare Practice Summary
Medicare Utilization ↗148,812
Medicare services
Top 1% in NC for optician
1,287
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~7,441 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 84,888 | $5 | $15 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
33,700 | $10 | $45 |
| Denosumab injection (Prolia/Xgeva) | 9,551 | $18 | $44 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
8,775 | $34 | $105 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
6,643 | $26 | $144 |
| Hymovis intra-articular injection An injection of Hymovis, a hyaluronan derivative, administered directly into a joint space. |
1,344 | $13 | $40 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
1,257 | $1 | $10 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
631 | $98 | $267 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
491 | $92 | $175 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
447 | $53 | $151 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
266 | $21 | $59 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
207 | $121 | $350 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
176 | $1 | $5 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
97 | $36 | $125 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
79 | $77 | $225 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
52 | $4 | $20 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
43 | $11 | $50 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
41 | $28 | $96 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
40 | $26 | $80 |
| New patient office visit, complex (60-74 min) | 37 | $160 | $425 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
36 | $63 | $175 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
11 | $23 | $91 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
34.3% high complexity
65.1% medium
0.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$45,578
Total received (2018-2024)
Avg $6,511/year across 7 years
Top 5% in NC for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
777
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$30,845 (67.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,662 (30.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,071 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,388
2023
$4,401
2022
$2,290
2021
$5,136
2020
$20,261
2019
$9,521
2018
$1,581
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$516
AstraZeneca Pharmaceuticals LP
$291
ABBVIE INC.
$269
UCB, Inc.
$202
Novartis Pharmaceuticals Corporation
$175
GlaxoSmithKline, LLC.
$165
Mallinckrodt Hospital Products Inc.
$148
Janssen Biotech, Inc.
$126
GENZYME CORPORATION
$112
Aurinia Pharma U.S., Inc.
$64
Lilly USA, LLC
$55
PFIZER INC.
$48
SCILEX PHARMACEUTICALS INC.
$47
Boehringer Ingelheim Pharmaceuticals, Inc.
$39
ANI Pharmaceuticals, Inc.
$36
Fidia Pharma USA Inc.
$24
Radius Health, Inc.
$21
SOBI, INC
$20
Organon Llc
$17
Genentech USA, Inc.
$14
Top 3 companies account for 45.0% of 2024 payments
All-time payments by company (2018-2024) ›
United Rheumatology
$28,750
Janssen Biotech, Inc.
$3,091
Amgen Inc.
$2,639
Horizon Therapeutics plc
$1,604
UCB, Inc.
$1,442
GlaxoSmithKline, LLC.
$954
PFIZER INC.
$675
AstraZeneca Pharmaceuticals LP
$646
Novartis Pharmaceuticals Corporation
$616
Mallinckrodt Hospital Products Inc.
$559
ABBVIE INC.
$510
Genentech USA, Inc.
$472
AbbVie, Inc.
$411
Lilly USA, LLC
$400
Aurinia Pharma U.S., Inc.
$334
AbbVie Inc.
$243
Actelion Pharmaceuticals US, Inc.
$223
Radius Health, Inc.
$221
E.R. Squibb & Sons, L.L.C.
$219
GENZYME CORPORATION
$161
Celgene Corporation
$143
Boehringer Ingelheim Pharmaceuticals, Inc.
$135
Regeneron Healthcare Solutions, Inc.
$133
Hikma Pharmaceuticals USA
$128
FIDIA PHARMA USA INC.
$118
Fresenius Kabi USA, LLC
$103
Organon LLC
$96
FUJIFILM SonoSite, Inc.
$50
SCILEX PHARMACEUTICALS INC.
$47
Horizon Pharma plc
$44
ANI Pharmaceuticals, Inc.
$36
Sandoz Inc.
$34
Merck Sharp & Dohme Corporation
$28
BOSTON SCIENTIFIC CORPORATION
$25
Bioventus LLC
$24
Fidia Pharma USA Inc.
$24
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$23
Mallinckrodt LLC
$22
Mallinckrodt Enterprises LLC
$20
SOBI, INC
$20
Aziyo Biologics, Inc.
$19
SANOFI-AVENTIS U.S. LLC
$17
Organon Llc
$17
MEDEXUS PHARMA, INC.
$15
Avanir Pharmaceuticals, Inc.
$14
Alexion Pharmaceuticals, Inc.
$14
BioCryst Pharmaceuticals, Inc.
$12
Ironwood Pharmaceuticals, Inc
$12
Synergy Pharmaceuticals Inc
$11
West-Ward Pharmaceuticals
$11
DePuy Synthes Sales Inc.
$11
Top 3 companies account for 75.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Aimovig · BENLYSTA · Bimzelx · CHANTIX · COSENTYX · CYLTEZO · Cimzia · Durolane · ECM · EVENITY · EVUSHELD · Enbrel · FORTEO · GENERAL PAIN MANAGEMENT · GENERAL TACHY · HUMIRA · HYALGAN · HYMOVIS · HYRIMOZ · Humira · Hymovis · IDACIO · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · LINZESS · LUPKYNIS · LYRICA · Mitigare · NUEDEXTA · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · Otezla · POMPE - DISEASE · PREVNAR - 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Repatha · Rinvoq · Rituxan · SAPHNELO · SHINGRIX · SIMPONI · SIMPONI ARIA · SKYRIZI · SPIRIVA RESPIMAT · SYNVISC-ONE · Strensiq · TALTZ · TAVNEOS · TREMFYA · Trulance · Tymlos · UPTRAVI · VRAYLAR · X-Porte Ultrasound System · XELJANZ · XIFAXAN · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (68%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for optician in NC.
Geographic Context
Opticians within 10 mi
39
Per 100K population
33.2
County median income
$58,082
Nearest hospital
UNC HEALTH CARE WAYNE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hogarty is a mixed practice specialist, with above-average Medicare volume (top 1% in NC), with consulting-driven industry engagement in the top 5% of NC peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hogarty experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Hogarty performed 84,888 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hogarty receive payments from pharmaceutical companies?
Yes. Dr. Hogarty received a total of $45,578 from 51 companies across 777 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hogarty's costs compare to other opticians in Goldsboro?
Dr. Hogarty's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hogarty) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Goldsboro
Browse opticians in Goldsboro ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NC
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NC
Which NC opticians receive the most from drug and device companies.
By company
United Rheumatology Payments to Doctors
See all physicians who received payments from United Rheumatology.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology